$COMM, $DELL, $FRPT, $GHDX, $JYNT, $ORCL, $TSLA

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Friday follows:

CommScope Holding Company, Inc. (NASDAQ:COMM) was raised to Buy from Neutral but the price target was lowered to 19 from 20 at Goldman Sachs.

Dell Technologies Inc. (NYSE:DELL) was started as Buy and was assigned a 62 price target at Deutsche Bank. The firm noted that Dell’s risks of a slowdown in IT-infrastructure growth appears to already be priced into the shares after a recent 25% pullback.

Freshpet, Inc. (NASDAQ:FRPT) was started as Buy and was assigned a 60 target price at DA Davidson.

Genomic Health, Inc. (NASDAQ:GHDX) was raised to Overweight from Neutral with a 72 target price at Piper Jaffray.

The Joint Corporation (NASDAQ:JYNT) was started as Buy and was given a23 target price at B. Riley.

Oracle Corporation (NYSE:ORCL) was last seen up 6% at $55.92 and challenging all-time highs after beating earnings expectations and guiding for double-digit earnings growth based on its on-premise IT offerings, cloud and license support services all contributing to revenue growth. Wedbush Securities maintained its Neutral rating and $55 target price as the firm said it remains on the sidelines as it doesn’t see an inflection point in its infrastructure or cloud position

Tesla Inc. (NASDAQ:TSLA) was reiterated as Sell at Goldman Sachs, and the firm lowered its price target to 158 from 200. The firm sees a lower probability that upside volume scenarios will be achieved. Our call is 140 then 75 then bankruptcy.

Have a terrific weekend.

  analysts, buy, COMM, Dell, FRPT, GHDX, heffx, hold, ideas, JYNT, ORCL, sell, target, trade, TSLA

The following two tabs change content below.

• Bio
• Latest Posts

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

• The Street’s Key Stock Analysts Research Report - December 10, 2019
• Gold’s Great Year Points to Another - December 10, 2019
• Buy a New Ferrari to Drive, Buy the Stock as an Investment - December 9, 2019